CINCINNATI, March 14 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced that Senior Vice President and Chief Financial Officer Karl "Buzz" Brenkert, III will participate in the Lehman Brothers Eleventh Annual Global Healthcare Conference. The conference will be held at the Loews Miami Beach Hotel in Miami, Florida, March 18-20, 2008. Kendle's presentation is scheduled for Tuesday, March 18 at 2 p.m. Eastern Time.
The public is invited to listen to a live webcast of Kendle's presentation at http://www.kendle.com (click on the link provided in the Investor Events & Presentations section) or at http://cc.talkpoint.com/LEHM002/031808a_jw/default.asp?entity=Kendle . An archived version can be accessed following Kendle's presentation and will be available through April 18. Slides accompanying the presentation will be available by 9 a.m. Eastern Time on March 18 at http://www.kendle.com in the Investor Events & Presentations section.
Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world's biopharmaceutical companies maximize product life cycles and grow market share.
Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. We have conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. Kendle was named "Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 by leading global pharmaceutical publication Scrip.
Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.
|SOURCE Kendle International Inc.|
Copyright©2008 PR Newswire.
All rights reserved